Search

Your search keyword '"Moreno, Santiago"' showing total 3,218 results

Search Constraints

Start Over You searched for: "Moreno, Santiago" Remove constraint "Moreno, Santiago"
3,218 results on '"Moreno, Santiago"'

Search Results

51. Delayed gastrointestinal-associated lymphoid tissue reconstitution in duodenum compared with rectum in HIV-infected patients initiating antiretroviral therapy.

52. Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers

53. Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration

56. Fecal Microbiota Transplantation Alters the Proteomic Landscape of Inflammation in HIV: Identifying Bacterial Drivers

57. Phenology and aboveground net primary productivity of Panicum maximum pastoralist systems in the department of Moreno, Santiago del Estero, Argentina, derived from MODIS NDVI

62. GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases

63. Chlamydia Trachomatis Prevalence in Asymptomatic Women in Madrid: Study Findings and Their Association with Risk Factors and Mental Health.

64. Link Prediction for Cybersecurity Companies and Technologies: Towards a Survivability Score

66. Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway

69. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis

70. The ESSO core curriculum committee update on surgical oncology

71. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI)

72. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

75. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study

76. Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

77. Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy

79. Design of instruments for modeling economic and commercial behavior in bovine production

80. Inclusión de los alumnos con necesidades específicas de apoyo educativo. Una propuesta para el alumnado de la Facultad de Educación.

81. A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease

82. Proteomic snapshot of saliva samples predicts new pathways implicated in SARS-CoV-2 pathogenesis

83. Role of the dental surgeon in the early detection of adults with underlying HIV infection/AIDS

84. Strategies to Reduce the Use of Antibiotics in Fresh and Chilled Equine Semen

85. Interactions among the mycobiome, bacteriome, inflammation, and diet in people living with HIV

86. Weight changes after antiretroviral therapy initiation in CoRIS (Spain): a prospective multicentre cohort study

88. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV.

89. Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?

90. Design and Proof of Concept of a Web-Based Questionnaire to Identify Patients at Risk for HIV and HCV Infection.

91. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.

93. Safety and efficacy of the HIV-1 attachment inhibitor prodrug fostemsavir in heavily treatment-experienced individuals: week 96 results of the phase 3 BRIGHTE study

95. Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

96. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

98. Global variation in the long-term outcomes of ypT0 rectal cancers

99. Corrigendum: CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis

100. CD4/CD8 ratio and CD8+ T-cell count as prognostic markers for non-AIDS mortality in people living with HIV. A systematic review and meta-analysis

Catalog

Books, media, physical & digital resources